v3.8.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Income:    
Revenue
Expenses:    
Research and development 20,918 105,370
General and administrative 221,303 281,331
Interest 96,333 42,166
Total expenses 338,554 428,867
Net loss $ (338,554) $ (428,867)
Loss per share:    
Basic and diluted (in dollars per share) $ (0.005) $ (0.087)
Weighted average shares outstanding, basic and diluted (in shares) 67,278,621 4,939,182

Source